| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
- |
hepatocellular carcinoma |
MFN2 |
hsa-miR-615-5p, hsa-miR-1261 |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ_0009910 |
hepatocellular carcinoma |
MFN2 |
miR-1261 |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
- |
hsa_circRNA_100053 |
atrial fibrillation |
MFN2 |
hsa-miR-455-5p |
M
| DN |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
- |
hepatocellular carcinoma |
MFN2 |
hsa-miR-455-5p, hsa-miR-615-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
- |
- |
pulmonary arterial hypertension |
MFN2 |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
hsa_circRNA_100053 |
colorectal cancer |
MFN2 |
miR-574-3p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0006470 |
- |
gastric cancer |
MFN2 |
- |
Q
| DN |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
Circ0009910 |
colorectal cancer |
MFN2 |
miR-145-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
- |
ovarian cancer |
MFN2 |
miR-145 |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ_0009910 |
acute myeloid leukemia |
MFN2 |
miR-5195-3p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
- |
- |
Wilms tumor |
MFN2 |
miR-372-3p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circMFN2 |
hepatocellular carcinoma |
MFN2 |
miR-361-3p |
Q
H
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
- |
COVID-19 |
MFN2 |
hsa-miR-145-5p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
- |
circMFN2 |
pulmonary hypertension |
MFN2 |
- |
Q
H
| DN |
More |
| Human |
hsa_circ_MFN2 |
- |
circMFN2 |
pituitary gland adenoma |
MFN2 |
miR-146a-3p |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ_0009910 / circ0009910 |
breast cancer |
MFN2 |
miR-145-5p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ9910 |
cervical cancer |
MFN2 |
miR-198 |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009912 |
hsa_circRNA_100053 |
hepatocellular carcinoma |
MFN2 |
hsa-miR-187-3p, hsa-miR-145-5p |
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ_0009910 / circ-0009910 |
hepatocellular carcinoma |
MFN2 |
- |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0006470 |
circMFN2 |
toxic encephalopathy |
MFN2 |
- |
S
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circRNA_0009910 / circ_0009910 |
osteosarcoma |
MFN2 |
miR-449a |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ_0009910 / hsa_circRNA_100053 |
acute myeloid leukemia |
- |
miR-20a-5p |
Q
M
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circ_0009910 |
chronic myelogenous leukemia, BCR-ABL1 positive |
MFN2 |
miR-34a-5p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
Circ_0009910 |
gastric cancer |
MFN2 |
miR-361-3p |
Q
| UP |
More |
| Human |
hsa_circ_MFN2 |
hsa_circ_0009910 |
circRNA mitofusin 2 / circMFN2 |
ovarian cancer |
MFN2 |
miR-198 |
Q
| UP |
More |